MS
VRTX icon

Maven Securities’s Vertex Pharmaceuticals VRTX Stock Holding History

Maven Securities’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,600
Closed -$651K – 989
2023
Q4 		$651K Sell
1,600
-3,800
-70% -$1.4M 0.01% 587
2023
Q3 		$1.88M Buy
+5,400
New +$1.89M 0.02% 421
2022
Q3 		– Sell
-1,800
Closed -$507K – 1235
2022
Q2 		$507K Buy
+1,800
New +$482K 0.02% 569
2021
Q4 		– Sell
-1,300
Closed -$236K – 1168
2021
Q3 		$236K Buy
1,300
+100
+8% +$19.5K 0.01% 918
2021
Q2 		$242K Sell
1,200
-2,500
-68% -$523K 0.01% 893
2021
Q1 		$795K Buy
+3,700
New +$813K 0.04% 496
2020
Q4 		– Sell
-8,000
Closed -$2.19M – 870
2020
Q3 		$2.19M Buy
8,000
+2,900
+57% +$800K 0.18% 124
2020
Q2 		$1.48M Buy
5,100
+3,600
+240% +$976K 0.1% 166
2020
Q1 		$357K Buy
1,500
+500
+50% +$115K 0.04% 208
2019
Q4 		$217K Buy
+1,000
New +$202K 0.02% 336

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return